Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Income from Non-Controlling Interests came in at $200000.0 in Q1 2026, down 66.67% year-on-year from $600000.0 in Q1 2025, and up 113.33% quarter-over-quarter from -$1.5 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income from Non-Controlling Interests history runs 16 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests fell 66.67% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was -$400000.0, a 122.22% decrease from a year earlier, with the FY2025 full-year figure at -$100000.0, down 106.67% from the prior year.
- Income from Non-Controlling Interests climbed to $200000.0 in Q1 2026 per ZBH's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $700000.0 in Q4 2024 and bottomed at -$1.5 million in Q4 2025.
- The 5-year median for Income from Non-Controlling Interests is $300000.0 (2022), against an average of $229411.8.
- Across the five-year window, Income from Non-Controlling Interests jumped 200.0% in 2022 and tumbled 314.29% in 2025, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $300000.0 in 2022, then jumped by 66.67% to $500000.0 in 2023, then surged by 40.0% to $700000.0 in 2024, then plunged by 314.29% to -$1.5 million in 2025, then surged by 113.33% to $200000.0 in 2026.
- Per Business Quant, the three latest ZBH Income from Non-Controlling Interests figures stand at $200000.0 (Q1 2026), -$1.5 million (Q4 2025), and $300000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Zimmer Biomet Holdings | 18.03 Bn | 17.61 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 600,000.00 |